Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Kathy Albain, Loyola University
ClinicalTrials.gov Identifier:
NCT00756717
First received: September 19, 2008
Last updated: April 1, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2018
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
No publications provided by Loyola University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):